BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3909671)

  • 1. Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy.
    Taal BG; Schalm SW
    Z Gastroenterol; 1985 May; 23(5):228-34. PubMed ID: 3909671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
    Wolfhagen FH; van Buuren HR; Schalm SW
    Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological characteristics of primary biliary cirrhosis patients].
    Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP; Sipponen P; Ikkala E; Kolho L; Makkonen HM; Miettinen TA; Räsänen JA; Siurala M
    Ann Clin Res; 1976 Jun; 8(3):206-15. PubMed ID: 63265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of antimitochondrial antibodies].
    Rüegg R; Matter L; Schopfer K; Grob PJ
    Schweiz Med Wochenschr; 1985 Mar; 115(9):290-6. PubMed ID: 3983600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
    Taylor SL; Dean PJ; Riely CA
    Am J Surg Pathol; 1994 Jan; 18(1):91-9. PubMed ID: 8279631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in the diagnosis and treatment of primary biliary liver cirrhosis].
    Salupere VP; Remmel' KhA; Uĭbo RM
    Ter Arkh; 1987; 59(2):112-4. PubMed ID: 3576463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlation of antimitochondrial antibodies.
    Zuber MA; Recktenwald C
    Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis.
    Sotaniemi EA; Hynnynen T; Ahlqvist J; Ahokas JT; Puoskari U; Pelkonen I
    J Med; 1978; 9(2):117-28. PubMed ID: 276564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K; Cueni B; Schmid M
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1749-52. PubMed ID: 929135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis.
    von Landenberg P; Baumgartner M; Schoelmerich J; Lackner KJ; Klein R
    Ann N Y Acad Sci; 2005 Jun; 1051():20-8. PubMed ID: 16126941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the laboratory affect the investigation and diagnosis of primary biliary cirrhosis?
    Sinclair D; Spedding A; Young R
    J Clin Pathol; 2006 Apr; 59(4):360-2. PubMed ID: 16461570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP; Laitinen OI; Lehtola J; Makkonen H; Räsänen JA; Sipponen P
    Scand J Gastroenterol; 1976; 11(3):313-20. PubMed ID: 1273506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis in India.
    Sarin SK; Monga R; Sandhu BS; Sharma BC; Sakhuja P; Malhotra V
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):105-9. PubMed ID: 16481294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases.
    Ballot E; Bandin O; Chazouilleres O; Johanet C; Poupon R
    J Autoimmun; 2004 Mar; 22(2):153-8. PubMed ID: 14987744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in primary biliary cirrhosis.
    Taal BG
    Neth J Med; 1981; 24 Suppl 1():1-30. PubMed ID: 7322249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.